Use of complementary and alternative medicine in children with cancer: Effect on survival

Simple item page
dc.contributor.buuauthorKaralı, Yasin
dc.contributor.buuauthorDemirkaya, Metin
dc.contributor.buuauthorSevinir, Betül
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-0710-5422tr_TR
dc.contributor.researcheridC-7392-2019tr_TR
dc.contributor.researcheridAAH-1570-2021tr_TR
dc.contributor.scopusid49863694000tr_TR
dc.contributor.scopusid24331130000tr_TR
dc.contributor.scopusid6603199915tr_TR
dc.date.accessioned2022-04-13T13:40:20Z
dc.date.available2022-04-13T13:40:20Z
dc.date.issued2012-05
dc.description.abstractThe objective of the present study was to determine the type, frequency, the reason why complementary and alternative medicine (CAM) treatments are used, the factors related with their use, and the effects of CAM usage on long-term survival. Families of a total of 120 children with cancer between 0-18 years of age, including 50 (41.7%) girls and 70 (58.3%) boys, participated in our study. The authors found that 88 patients (73.3%) used at least one CAM method, the most common (95.5%) of which was biologically based therapies. Most frequently used biologically based therapies were dietary supplements and herbal products. The most commonly used dietary supplement or herbal product was honey (43.2%) or stinging nettle (43.2%), respectively. We found that patients used such CAM methods as complementary to, but not instead of, conventional therapy. Sixty-nine out of 88 patient families (78.4%) shared the CAM method they used with their physicians. No statistically significant relation was found between socioeconomic, sociodemographic, or other factors or items and CAM use. The mean follow-up period of the CAM users and nonusers groups was 79.4 +/- 36.7 (21.3-217.9) and 90.9 +/- 50.3 (27.4-193.7) months, respectively. Five-year survival rates for CAM users and nonusers were found as 81.5% and 86.5%, respectively (P > .05). In conclusion, families of children with cancer use complementary and alternative treatment frequently. They do not attempt to replace conventional treatment with CAM. Higher rates of CAM use was found in families with higher educational level. CAM usage did not affect the long-term survival.en_US
dc.identifier.citationKaralı, Y. vd. (2012). "Use of complementary and alternative medicine in children with cancer: Effect on survival". Pediatric Hematology and Oncology, 29(4), 335-344.en_US
dc.identifier.endpage344tr_TR
dc.identifier.issn0888-0018
dc.identifier.issue4tr_TR
dc.identifier.pubmed22568796tr_TR
dc.identifier.scopus2-s2.0-84860850481tr_TR
dc.identifier.startpage335tr_TR
dc.identifier.urihttps://doi.org/10.3109/08880018.2012.670368
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.3109/08880018.2012.670368
dc.identifier.urihttp://hdl.handle.net/11452/25764
dc.identifier.volume29tr_TR
dc.identifier.wos000303832800005tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.relation.journalPediatric Hematology and Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOncologyen_US
dc.subjectHematologyen_US
dc.subjectPediatricsen_US
dc.subjectAlternative treatmenten_US
dc.subjectCanceren_US
dc.subjectChildrenen_US
dc.subjectComplementary medicineen_US
dc.subjectPediatric oncology patientsen_US
dc.subjectTherapiesen_US
dc.subjectTurkeyen_US
dc.subject.emtreeAdolescenten_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAlternative medicineen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCancer survivalen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeDemographyen_US
dc.subject.emtreeDiet supplementationen_US
dc.subject.emtreeEducationen_US
dc.subject.emtreeFamilyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHodgkin diseaseen_US
dc.subject.emtreeHoneyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInfanten_US
dc.subject.emtreeLong term survivalen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNephroblastomaen_US
dc.subject.emtreeNeuroblastomaen_US
dc.subject.emtreeNewbornen_US
dc.subject.emtreeNonhodgkin lymphomaen_US
dc.subject.emtreeOsteosarcomaen_US
dc.subject.emtreePhysicianen_US
dc.subject.emtreePreschool childen_US
dc.subject.emtreeSchool childen_US
dc.subject.emtreeSocioeconomicsen_US
dc.subject.emtreeSoft tissue sarcomaen_US
dc.subject.emtreeSurvival rateen_US
dc.subject.meshChilden_US
dc.subject.meshChild, preschoolen_US
dc.subject.meshComplementary therapiesen_US
dc.subject.meshDietary supplementsen_US
dc.subject.meshDisease-free survivalen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-up studiesen_US
dc.subject.meshHoneyen_US
dc.subject.meshAdolescenten_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshInfant, newbornen_US
dc.subject.meshMaleen_US
dc.subject.meshNeoplasmsen_US
dc.subject.meshPlants, medicinalen_US
dc.subject.meshSurvival rateen_US
dc.subject.meshUrtica dioicaen_US
dc.subject.scopusComplementary and Alternative Medicine; Homeopathy; Acupunctureen_US
dc.subject.wosOncologyen_US
dc.subject.wosHematologyen_US
dc.subject.wosPediatricsen_US
dc.titleUse of complementary and alternative medicine in children with cancer: Effect on survivalen_US
dc.typeArticle
dc.wos.quartileQ3 (Pediatrics)en_US
dc.wos.quartileQ4en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science
PubMed
Scopus